Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder

Stopped early · Phase 4

Conditions studied: Major Depressive Disorder, Depression, Depressive Disorder, Depressive Episode, Depression, Unipolar

In brief

This study aims to determine whether the GeneSight Psychotropic test can result in better treatment outcomes for patients with treatment-naive major depressive disorder

Key facts

Study ID

NCT03537547

Run by

Washington University School of Medicine

People needed

6

Starts

2018-05-04

Expected to finish

2019-08-19

Last updated by the study team

2020-06-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults 18-65 years of age
• Treatment-naïve major depressive disorder meeting Diagnostic and Statistical Manual 4th Edition (DSM-IV) criteria, without psychosis
• Total baseline score on the Quick Inventory Of Depressive Symptomatology Clinician-rated (QIDS-C16) and the Quick Inventory Of Depressive Symptomatology Self-Report (QIDS-SR16) rating scale ≥11
• Good command of the English language

You may not qualify if…

• Patients with a current diagnosis of schizophrenia
• Patients with a current diagnosis of schizoaffective disorder
• Patients with a current diagnosis of bipolar disorder (any type)
• Currently meeting DSM-IV criteria for significant substance use disorder (exception: nicotine use disorder)
• A diagnosis of personality disorder that may interfere with the patient's ability to improve on pharmacologic treatment, as determined by study investigator
• Patients currently receiving electroconvulsive therapy(ECT), deep brain stimulation (DBS) or transcranial magnetic stimulation (TMS) treatment
• History of hypothyroidism unless taking a stable dose of thyroid medication and asymptomatic or euthyroid for 6 months
• Significant unstable medical condition; life threatening disease; hepatic insufficiency; liver transplant recipient; cirrhosis of the liver; need for therapies that may obscure the results of treatment and/or of the study; malignancy (except basal cell carcinoma) and/or chemotherapy within 1 year prior to screening; malignancy more than 1 year prior to screening must have been local and without metastasis and/or recurrence, and if treated with chemotherapy, without nervous system complications
• History of gastric bypass surgery
• Acute suicidal intention and/or in need of immediate hospitalization as judged by the investigator
• Active psychotic symptoms
• Currently in an inpatient facility
• History of prior pharmacogenomic testing
• Currently pregnant or lactating
• Inability to provide informed consent
• Any other factor that in the investigators' judgment may affect patient safety or compliance

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.